Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population

BACKGROUND: The association of recombinant FSH (rFSH) plus recombinant LH (rLH) is currently used for Controlled Ovarian Stimulation (COS) in human IVF, but its efficacy has, to date, not yet been compared to that of human Menopausal Gonadotropin (hMG), the FSH + LH activity-containing urinary drug....

Descripción completa

Detalles Bibliográficos
Autores principales: Revelli, Alberto, Pettinau, Grazia, Basso, Gemma, Carosso, Andrea, Ferrero, Alessandro, Dallan, Cecilia, Canosa, Stefano, Gennarelli, Gianluca, Guidetti, Daniela, Filippini, Claudia, Benedetto, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514947/
https://www.ncbi.nlm.nih.gov/pubmed/26209525
http://dx.doi.org/10.1186/s12958-015-0080-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514947/
https://www.ncbi.nlm.nih.gov/pubmed/26209525
http://dx.doi.org/10.1186/s12958-015-0080-6

Ejemplares similares